Latest filing published 12 Nov 2026 for vTv Therapeutics Inc., €1.2M.
Insider track record
Samsara BioCapital, L.P.: trading record in brief
Samsara BioCapital, L.P. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Septerna, Inc. and vTv Therapeutics Inc. We count 2 filings, every one of them for a trade on 12 November 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 12 November 2026: a transaction of €1.2M, in vTv Therapeutics Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Samsara BioCapital, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 61,287 shares@ US$21.471.25% mcap100.0% of flowCommon StockSEC144:0001628280-26-073518
- 306,645 shares@ US$48.560.64% mcap100.0% of flowCommon StockSEC144:0001628280-26-073519
2 of 2 declarations